CARDIO CONSULT / PEER REVIEWED

How Do I Use the New Cholesterol Guidelines?

Author and Disclosure Information

 

References

Q) I’m still confused by the change in approach to use of statin therapy for cardiovascular disease. How do I determine which patients need statins?

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in adults in the United States.1 Statins have long been recommended in the management of individuals with ASCVD.

Historically, statin use was guided by an LDL cholesterol (LDL-C) target, per the Adult Treatment Panel (ATP III) guidelines. Therapy was intensified based on whether patients met these targets. Newer guidelines from the American Heart Association/American College of Cardiology (AHA/ACC) base statin therapy not on an LDL-C number but rather on risk stratification that considers several factors.1-3

Continue to: The AHA/ACC guidelines classify statins as...

Pages

Recommended Reading

Declining lung function linked to heart failure, stroke
Clinician Reviews
No Walk in the Park
Clinician Reviews
Diclofenac’s cardiovascular risk confirmed in novel Nordic study
Clinician Reviews
Rivaroxaban bonus: Early unmasking of occult GI cancers
Clinician Reviews
Under new ACC-AHA criteria, more pregnant women at risk of hypertension, adverse outcomes
Clinician Reviews
The Rancher, the Roof, and the Rogue Heart
Clinician Reviews
Home telemonitoring for heart failure cuts mortality
Clinician Reviews
GARFIELD-AF registry: DOACs cut mortality 19%
Clinician Reviews
Rivaroxaban gains indication for prevention of major cardiovascular events in CAD/PAD
Clinician Reviews
Time reveals benefit of CABG over PCI for left main disease
Clinician Reviews